OmniStar Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,476
Closed -$351K 142
2023
Q4
$351K Sell
3,476
-3,182
-48% -$307K 0.44% 69
2023
Q3
$681K Sell
6,658
-120
-2% -$12.2K 0.81% 41
2023
Q2
$684K Sell
6,778
-854
-11% -$85.4K 0.8% 45
2023
Q1
$702K Sell
7,632
-370
-5% -$32.3K 0.89% 40
2022
Q4
$726K Buy
8,002
+76
+1% +$6.4K 0.82% 46
2022
Q3
$602K Sell
7,926
-1,074
-12% -$89K 0.72% 52
2022
Q2
$760K Buy
9,000
+163
+2% +$14.3K 0.84% 46
2022
Q1
$775K Buy
8,837
+468
+6% +$40.5K 0.77% 49
2021
Q4
$732K Buy
8,369
+22
+0.3% +$1.83K 0.75% 57
2021
Q3
$682K Buy
+8,347
New +$751K 0.81% 48
2021
Q2
Sell
-8,286
Closed -$738K 157
2021
Q1
$708K Sell
8,286
-6,218
-43% -$558K 0.9% 42
2020
Q4
$1.37M Sell
14,504
-599
-4% -$52.3K 0.96% 37
2020
Q3
$1.31M Sell
15,103
-189
-1% -$16.4K 0.99% 34
2020
Q2
$1.34M Buy
+15,292
New +$1.32M 1.1% 29

Other funds holding NVS

OmniStar Financial Group's NVS Position: Q1 2024 in Review

OmniStar Financial Group sold out of Novartis (NVS) in Q1 2024, closing a stake of 3,476 shares — an estimated $351K sold.

OmniStar Financial Group first reported a position in NVS in Q2 2020 and held it in 14 quarters. The position peaked at $1.37M in Q4 2020. 1,254 funds tracked by Wall St. Rank hold NVS as of Q1 2024.

  • OmniStar Financial Group reported no remaining Novartis position as of Q1 2024 after selling out during the quarter.
  • OmniStar Financial Group sold 3,476 Novartis shares in Q1 2024, an estimated $351K.
  • OmniStar Financial Group first reported a position in Novartis in Q2 2020 and held it in 14 quarters.
  • OmniStar Financial Group's Novartis position peaked at $1.37M in Q4 2020.
  • 1,254 funds tracked by Wall St. Rank held Novartis as of Q1 2024.

Based on OmniStar Financial Group's 13F filing for Q1 2024, filed 23 Apr 2024.